Vitamins B2 and B6 and genetic polymorphisms related to one-carbon metabolism as risk factors for gastric adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition

Cancer Epidemiology Biomarkers and Prevention

Volumn 19, Issue 1, 2010, Pages 28-38

  Eussen, Simone J P M ^a   Vollset, Stein Emil ^a,b   Hustad, Steinar ^a,c   Midttun, Øivind ^a,d   Meyer, Klaus ^a   Fredriksen, Åse ^a   Ueland, Per Magne ^a   Jenab, Mazda ^e   Slimani, Nadia ^e   Ferrari, Pietro ^e   Agudo, Antonio ^f   Sala, Núria ^g   Capellá, Gabriel ^h   Del Giudice, Giuseppe ⁱ   Palli, Domenico ^j   Boeing, Heiner ^k   Weikert, Cornelia ^k   Bueno de Mesquita, H Bas ^l   Büchner, Frederike L ^l   Carneiro, Fátima ^m   Berrino, Franco ⁿ   Vineis, Paolo ^o,p   Tumino, Rosario ^q   Panico, Salvatore ^r   Berglund, Göran ^s   Manjer, Jonas ^t   Stenling, Roger ^u   Hallmans, Göran ^u   Martínez, Carmen ^v,w   Arrizola, Larraitz ^w,x   Barricarte, Aurelio ^w,y   Navarro, Carmen ^w,z   Rodriguez, Laudina ^aa   Bingham, Sheila ^ab,ac   Linseisen, Jakob ^ad,ae   Kaaks, Rudolf ^ad   Overvad, Kim ^af   Tjønneland, Anne ^ag   Peeters, Petra H M ^o,ah   Numans, Mattijs E ^ah   Clavel Chapelon, Françoise ^ai   Boutron Ruault, Marie Christine ^ai   Morois, Sophie ^ai   Trichopoulou, Antonia ^aj   Lund, Eiliv ^ak   Plebani, Mario ^al   Riboli, Elio ^o   González, Carlos A ^f   more..

^a UNIVERSITY OF BERGEN   (Norway)

^b NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^d BEVITAL AS   (Norway)

^e INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^f CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^g Environment and Cancer   (Spain)

^h Transitional Laboratory Research ICO   (Spain)

ⁱ NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

^j Scientific Institute of Tuscany   (Italy)

^k GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^l NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^m University of Porto   (Portugal)

ⁿ NATIONAL CANCER INSTITUTE   (Italy)

^o IMPERIAL COLLEGE LONDON   (United Kingdom)

^p UNIVERSITY OF TURIN   (Italy)

^q CIVILE M P AREZZO HOSPITAL   (Italy)

^r UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^s LUND UNIVERSITY   (Sweden)

^t LUND UNIVERSITY HOSPITAL   (Sweden)

^u UMEÅ UNIVERSITY   (Sweden)

^v ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^w CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^x Public Health Institute of Navarra ^*  (Spain)

^y INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^z DEPARTMENT OF EPIDEMIOLOGY   (Spain)

^aa Public Health and Health Planning Directorate   (Spain)

^ab UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^ac UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^ad GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^ae INSTITUTE OF EPIDEMIOLOGY   (Germany)

^af AALBORG UNIVERSITY HOSPITAL   (Denmark)

^ag INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^ah UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^ai INSERM   (France)

^aj UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^ak UNIVERSITY OF TROMSØ   (Norway)

^al UNIVERSITY OF PADOVA   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FLAVINE MONONUCLEOTIDE; PYRIDOXAL; PYRIDOXAL 5 PHOSPHATE; PYRIDOXIC ACID; PYRIDOXINE; RIBOFLAVIN;

ADULT; AGED; ARTICLE; ATROPHIC GASTRITIS; BLOOD SAMPLING; CANCER RISK; CARBON METABOLISM; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HELICOBACTER INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; STOMACH ADENOCARCINOMA; VITAMIN BLOOD LEVEL;

ADENOCARCINOMA; CASE-CONTROL STUDIES; CHROMATOGRAPHY, LIQUID; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; ONE-CARBON GROUP TRANSFERASES; POLYMORPHISM, SINGLE NUCLEOTIDE; RIBOFLAVIN; RISK FACTORS; STOMACH NEOPLASMS; VITAMIN B 6;

EID: 74549222230     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-08-1096     Document Type: Article

References (66)

1. Verdecchia A, Mariotto A, Gatta G, Bustamante-Teixeira MT, Ajiki W. Comparison of stomach cancer incidence and survival in four continents. Eur J Cancer 2003;39:1603-9.
2. Webb PM, Law M, Varghese C, et al. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001;49:347-53.
3. Schlemper RJ, van der Werf SD, Vandenbroucke JP, Biemond I, Lamers CB. Seroepidemiology of gastritis in Japanese and Dutch working populations: evidence for the development of atrophic gastritis that is not related to Helicobacter pylori. Gut 1995;37: 199-204.
4. Hustad S, Midttun Ø, Schneede J, et al. The methylenetetrahydrofolate reductase 677C→T polymorphism as a modulator of a B vitamin network with major effects on homocysteine metabolism. Am J Hum Genet 2007;80:846-55.
5. Bailey LB, Moyers S, Gregory JF. Present knowledge in nutrition. pp. 214-29Washington (DC): International Life Sciences Institute; 2001.
6. Larsson SC, Giovannucci E, Wolk A. Folate intake, MTHFR polymorphisms, and risk of esophageal, gastric, and pancreatic cancer: a meta-analysis. Gastroenterology 2006;131:1271-83.
7. Larsson SC, Giovannucci E, Wolk A. Folate intake and stomach cancer incidence in a prospective cohort of Swedish women. Cancer Epidemiol Biomarkers Prev 2006;15:1409-12.
8. Botterweck AA, van den Brandt PA, Goldbohm RA. Vitamins, carotenoids, dietary fiber, and the risk of gastric carcinoma: results from a prospective study after 6.3 years of follow-up. Cancer 2000;88: 737-48.
9. Vollset SE, Igland J, Jenab M, et al. The association of gastric cancer risk with plasma folate, cobalamin, and methylenetetrahydrofolate reductase polymorphisms in the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev 2007; 16:2416-24.
10. Mayne ST, Risch HA, Dubrow R, et al. Nutrient intake and risk of subtypes of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev 2001;10:1055-62.
11. Hsing AW, Hansson LE, McLaughlin JK, et al. Pernicious anemia and subsequent cancer. A population-based cohort study. Cancer 1993; 71:745-50.
12. Karlson BM, Ekbom A, Wacholder S, McLaughlin JK, Hsing AW. Cancer of the upper gastrointestinal tract among patients with pernicious anemia: a case-cohort study. Scand J Gastroenterol 2000; 35:847-51.
13. Munoz N, Plummer M, Vivas J, et al. A case-control study of gastric cancer in Venezuela. Int J Cancer 2001;93:417-23.
14. Graham S, Haughey B, Marshall J, et al. Diet in the epidemiology of gastric cancer. Nutr Cancer 1990;13:19-34.
15. Cornee J, Pobel D, Riboli E, Guyader M, Hemon B. A case-control study of gastric cancer and nutritional factors in Marseille, France. Eur J Epidemiol 1995;11:55-65.
16. Harrison LE, Zhang ZF, Karpeh MS, Sun M, Kurtz RC. The role of dietary factors in the intestinal and diffuse histologic subtypes of gastric adenocarcinoma: a case-control study in the U.S. Cancer 1997;80:1021-8.
17. Zhang ZF, Kurtz RC, Yu GP, et al. Adenocarcinomas of the esophagus and gastric cardia: the role of diet. Nutr Cancer 1997;27:298-309.
18. Kaaks R, Tuyns AJ, Haelterman M, Riboli E. Nutrient intake patterns and gastric cancer risk: a case-control study in Belgium. Int J Cancer 1998;78:415-20.
19. Risch HA, Jain M, Choi NW, et al. Dietary factors and the incidence of cancer of the stomach. Am J Epidemiol 1985;122:947-59.
20. Ji BT, Chow WH, Yang G, et al. Dietary habits and stomach cancer in Shanghai, China. Int J Cancer 1998;76:659-64.
21. Kim HJ, Kim MK, Chang WK, et al. Effect of nutrient intake and Helicobacter pylori infection on gastric cancer in Korea: a casecontrol study. Nutr Cancer 2005;52:138-46.
22. Lowik MR, van den Berg H, Kistemaker C, Brants HA, Brussaard JH. Interrelationships between riboflavin and vitamin B6 among elderly people (Dutch Nutrition Surveillance System). Int J Vitam Nutr Res 1994;64:198-203.
23. McCormick DB. Two interconnected B vitamins: riboflavin and pyridoxine. Physiol Rev 1989;69:1170-98.
24. Zintzaras E. Association of methylenetetrahydrofolate reductase (MTHFR) polymorphisms with genetic susceptibility to gastric cancer: a meta-analysis. J Hum Genet 2006;51:618-24.
25. Ott N, Geddert H, Sarbia M. Polymorphisms in methionine synthase (A2756G) and cystathionine β-synthase (844ins68) and susceptibility to carcinomas of the upper gastrointestinal tract. J Cancer Res Clin Oncol 2008;134:405-10.
26. Stolzenberg-Solomon RZ, Qiao YL, Abnet CC, et al. Esophageal and gastric cardia cancer risk and folate- and vitamin B(12)-related polymorphisms in Linxian, China. Cancer Epidemiol Biomarkers Prev 2003;12:1222-6.
27. Zhang FF, Terry MB, Hou L, et al. Genetic polymorphisms in folate metabolism and the risk of stomach cancer. Cancer Epidemiol Biomarkers Prev 2007;16:115-21.
28. Wang L, Ke Q, Chen W, et al. Polymorphisms of MTHFD, plasma homocysteine levels, and risk of gastric cancer in a high-risk Chinese population. Clin Cancer Res 2007;13:2526-32.
29. Gotze T, Rocken C, Rohl FW, et al. Gene polymorphisms of folate metabolizing enzymes and the risk of gastric cancer. Cancer Lett 2007.
30. Riboli E, Hunt KJ, Slimani N, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 2002;5:1113-24.
31. Riboli E, Kaaks R, European Prospective Investigation into Cancer and Nutrition. The EPIC Project: rationale and study design. Int J Epidemiol 1997;26 Suppl 1:S6-14.
32. Carneiro F, Moutinho C, Pera G, et al. Pathology findings and validation of gastric and esophageal cancer cases in a European cohort (EPIC/EUR-GAST). Scand J Gastroenterol 2007;42:618-27.
33. Midttun Ø, Hustad S, Solheim E, Schneede J, Ueland PM. Multianalyte quantification of vitamin B6 and B2 species in the nanomolar range in human plasma by liquid chromatography-tandem mass spectrometry. Clin Chem 2005;51:1206-16.
34. Meyer K, Fredriksen A, Ueland PM. High-level multiplex genotyping of polymorphisms involved in folate or homocysteine metabolism by matrix-assisted laser desorption/ionization mass spectrometry. Clin Chem 2004;50:391-402.
35. Koushik A, Kraft P, Fuchs CS, et al. Nonsynonymous polymorphisms in genes in the one-carbon metabolism pathway and associations with colorectal cancer. Cancer Epidemiol Biomarkers Prev 2006;15: 2408-17.
36. Palli D, Masala G, Del Giudice G, et al. CagA+ Helicobacter pylori infection and gastric cancer risk in the EPIC-EURGAST study. Int J Cancer 2007;120:859-67.
37. Foraker AB, Khantwal CM, Swaan PW. Current perspectives on the cellular uptake and trafficking of riboflavin. Adv Drug Deliv Rev 2003; 55:1467-83.
38. Merrill AH, Jr., McCormick DB. Affinity chromatographic purification and properties of flavokinase (ATP:riboflavin 5'-phosphotransferase) from rat liver. J Biol Chem 1980;255:1335-8.
39. Yamada Y, Merrill AH, Jr., McCormick DB. Probable reaction mechanisms of flavokinase and FAD synthetase from rat liver. Arch Biochem Biophys 1990;278:125-30.
40. Karthikeyan S, Zhou Q, Mseeh F, et al. Crystal structure of human riboflavin kinase reveals a â barrel fold and a novel active site arch. Structure 2003;11:265-73.
41. Leklem J. Present knowledge in nutrition. pp. 174-83Washington (DC): ILSI Press; 1996.
42. Coburn SP. Modeling vitamin B6 metabolism. Adv Food Nutr Res 1996;40:107-32.
43. Knol MJ, Vandenbroucke JP, Scott P, Egger M. What do case-control studies estimate? Survey of methods and assumptions in published case-control research. Am J Epidemiol 2008.
44. Midttun Ø, Hustad S, Schneede J, Vollset SE, Ueland PM. Plasma vitamin B-6 forms and their relation to transsulfuration metabolites in a large, population-based study. Am J Clin Nutr 2007;86:131-8.
45. Carmel R. Cobalamin, the stomach, and aging. Am J Clin Nutr 1997; 66:750-9.
46. Weck MN, Brenner H. Prevalence of chronic atrophic gastritis in different parts of the world. Cancer Epidemiol Biomarkers Prev 2006; 15:1083-94.
47. Bates CJ, Pentieva KD, Prentice A. An appraisal of vitamin B6 status indices and associated confounders, in young people aged 4-18 years and in people aged 65 years and over, in two national British surveys. Public Health Nutr 1999;2:529-35.
48. Chiang EP, Smith DE, Selhub J, et al. Inflammation causes tissue-specific depletion of vitamin B6. Arthritis Res Ther 2005;7: R1254-62.
49. Gori AM, Sofi F, Marcucci R, et al. Association between homocysteine, vitamin B(6) concentrations and inflammation. Clin Chem Lab Med 2007;45:1728-36.
50. Kekki M, Samloff IM, Varis K, Ihamaki T. Serum pepsinogen I and serum gastrin in the screening of severe atrophic corpus gastritis. Scand J Gastroenterol Suppl 1991;186:109-16.
51. Hustad S, McKinley MC, McNulty H, et al. Riboflavin, flavin mononucleotide, and flavin adenine dinucleotide in human plasma and erythrocytes at baseline and after low-dose riboflavin supplementation. Clin Chem 2002;48:1571-7.
52. Powers HJ. Riboflavin (vitamin B-2) and health. Am J Clin Nutr 2003; 77:1352-60.
53. Tuyns AJ, Kaaks R, Haelterman M, Riboli E. Diet and gastric cancer. A case-control study in Belgium. Int J Cancer 1992;51:1-6.
54. Gonzalez CA, Pera G, Agudo A, et al. Fruit and vegetable intake and the risk of stomach and oesophagus adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Int J Cancer 2006;118:2559-66.
55. IARC. Fruit and vegetables. IARC handbook of cancer prevention. Lyon (France): IARC Press; 2003.
56. Riboli E, Norat T. Epidemiologic evidence of the protective effect of fruit and vegetables on cancer risk. Am J Clin Nutr 2003;78: 559-69S.
57. Gonzalez CA, Jakszyn P, Pera G, et al. Meat intake and risk of stomach and esophageal adenocarcinoma within the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst 2006;98:345-54.
58. Webster RP, Gawde MD, Bhattacharya RK. Modulation of carcinogen-induced DNA damage and repair enzyme activity by dietary riboflavin. Cancer Lett 1996;98:129-35.
59. Pangrekar J, Krishnaswamy K, Jagadeesan V. Effects of riboflavin deficiency and riboflavin administration on carcinogen-DNA binding. Food Chem Toxicol 1993;31:745-50.
60. Komatsu S, Yanaka N, Matsubara K, Kato N. Antitumor effect of vitamin B6 and its mechanisms. Biochim Biophys Acta 2003;1647: 127-30.
61. Stabler SP, Lindenbaum J, Savage DG, Allen RH. Elevation of serum cystathionine levels in patients with cobalamin and folate deficiency. Blood 1993;81:3404-13.
62. Blount BC, Mack MM, Wehr CM, et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci U S A 1997;94:3290-5.
63. Choi SW, Kim YI, Weitzel JN, Mason JB. Folate depletion impairs DNA excision repair in the colon of the rat. Gut 1998;43:93-9.
64. Huang YC, Chen W, Evans MA, Mitchell ME, Shultz TD. Vitamin B-6 requirement and status assessment of young women fed a high-protein diet with various levels of vitamin B-6. Am J Clin Nutr 1998;67: 208-20.
65. Jarrard DF, Bova GS, Isaacs WB. DNA methylation, molecular genetic, and linkage studies in prostate cancer. Prostate Suppl 1996; 6:36-44.
66. Jones PA, Buckley JD. The role of DNA methylation in cancer. Adv Cancer Res 1990;54:1-23.